Get Funding for HIV Prevention in Mozambique
Posted: August 21, 2014
This grant closed on Oct 05, 2014. We have found similar active grants for you below.
Summary
This grant from the CDC supports organizations in Mozambique working to increase access to HIV prevention, care, and treatment services for key populations. Funding is available for evidence-based interventions aimed at reducing HIV transmission and improving health outcomes.
Eligibility
Full Description
The current FOA aims to support HIV preventive interventions in Mozambique targeting KP and OVP in provinces of Mozambique characterized by high prevalence of HIV, rapid development and increasing number of multinational companies, transport corridor areas, high mobility and transient male workforce, increased tourism, and increased HIV risk from commercial sex work and transactional sex, which together constitute some of the main factors driving the epidemic in Mozambique. A successful FOA respondent will support the adoption of combination prevention approaches targeting behavioral, biomedical, and structural interventions to ensure effective reach and impact on target population. Interventions aim to increase knowledge of HIV and sexually transmitted infections (STIs) among KP and other priority populations, reduce sexual risk behavior, increase knowledge and access to preventive commodities among target population. Interventions will also promote HIV testing and counseling (HTC) and create demand for the uptake of HTC services by KP and OVC, increase access to HIV, STI and tuberculosis (TB) services in addition to other health care services, and support access to universal coverage of HIV treatment for all eligible PLHIV within KP and OVP.
Interventions shall be carried out as part of a comprehensive package of HIV prevention interventions among KP and other priority populations, with focus on evidence-based prevention interventions (established interventions, such as volunteer male medical circumcision (VMMC); and potential future interventions, such as pre-exposure prophylaxis; diagnosis and control of sexually transmitted infections must also be considered); and establishment of a robust cascade for reach-test-treat-retain among KP and OVP.